Skip to main content
Clinical Trials/NCT00732329
NCT00732329
Completed
Not Applicable

Effectiveness of an Optimized Home Based Occupational Therapy for Patients With Dementia.

Technische Universität Dresden3 sites in 1 country160 target enrollmentAugust 2008
ConditionsDementia

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Dementia
Sponsor
Technische Universität Dresden
Enrollment
160
Locations
3
Primary Endpoint
Alzheimer's Disease Cooperative Study/Activities of Daily Living
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

The purpose of this study is to determine if a home based occupational therapy is effective in the treatment of dementia.

Registry
clinicaltrials.gov
Start Date
August 2008
End Date
January 2011
Last Updated
11 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Dr. Matthias Schützwohl

PD Dr.

Technische Universität Dresden

Eligibility Criteria

Inclusion Criteria

  • Dementia (according to DSM-IV TR)
  • A score 26 to 12 on the MMSE
  • Must be 55 or older
  • Patient is living at home or therapeutical flat sharing
  • Primary care giver at least 2 days / week available at home
  • Written informed consent from patient and care giver
  • German as dominant language

Exclusion Criteria

  • Other dementia (p.e. frontotemporal dementia, dementia with Lewy Bodies, Creutzfeldt-Jakob disease, Parkinson's disease or atypical Parkinson's syndromes
  • Dementia with relevant displaying behavioural problems (neuropsychiatric Inventory; NPI, Subscore ≥ 8)
  • Depressive episodes (Geriatric Depression Scale, GDS (short version) ≥ 6)
  • Mental disability
  • Home Based Occupational Therapy for Dementia within the last 6 months
  • Impairment of visual and/or acoustic cognition which does not allow Occupational Therapy
  • Apoplexy with movement disorders which does not allow Occupational Therapy
  • Severe physical/systemic illnesses (cardio-pulmonal, Hematological or metabolic) which do not allow participating
  • Recent history of addictive disorder
  • Intermittent intake of depressant medication, that likely causes an impairment of cognitive performance during the trial

Outcomes

Primary Outcomes

Alzheimer's Disease Cooperative Study/Activities of Daily Living

Time Frame: 2 weeks, 3 and 6 months after invention or 9, 19 and 31 weeks after randomization (treatment-as-usual-group)

Secondary Outcomes

  • - for patients: cognitive performance, displaying behavioural problems, satisfaction with occupational therapy, costs of occupational therapy - for family care givers: burden, medical condition, life-satisfaction(2 weeks, 3 and 6 months after invention or 9, 19 and 31 weeks after randomization (treatment-as-usual-group))

Study Sites (3)

Loading locations...

Similar Trials